Skip to main content

Noninvasive Urine Test for Cervical Cancer Shows Promise

Medically reviewed by Carmen Pope, BPharm. Last updated on July 9, 2024.

By Dennis Thompson HealthDay Reporter

TUESDAY, July 9, 2024 -- A new urine test might help doctors more easily screen for cervical cancer, researchers report.

The test looks for proteins generated by a type of cancer-causing human papillomavirus, HPV 16.

HPV strains 16 and 18 are responsible for nearly all cervical cancers, according to the National Cancer Institute.

These proteins, called E7 proteins, are associated with a high risk of cervical cancer, researchers said.

“Our new urine test can detect HPV16 E7 proteins, which are critical markers of cervical cancer risk, at extremely low levels,” said lead researcher Etsuro Ito, a professor of biology at Waseda University in Japan. “This means that women may be able to screen for cervical cancer without the discomfort and inconvenience of a traditional Pap test.”

The test detected E7 proteins in 80% of women with Stage 1 cervical intraepithelial neoplasia (CIN), a precursor to cervical cancer.

It also found the proteins in 71% of women with Stage 2 CIN and 38% of women with Stage 3 CIN, results show.

“We believe that the E7 oncoprotein is critical in the early stages of HPV-related cervical carcinogenesis and E7 may play a more significant role in the progression of CIN1 and CIN2 than in CIN3,” Ito said in a university news release.

The availability of a simple urine test could aid efforts to eradicate cervical cancer by eliminating barriers related to screening, researchers said.

“This new method holds great promise for early detection and prevention of cervical cancer,” Ito said. “We are optimistic that further development and validation of this assay will lead to its widespread use in clinical settings.”

The study was recently published in the journal Microorganisms.

Sources

  • Waseda University, news release, July 8, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2024

Read this next

FLiRTy Summer: All You Need to Know About the Latest COVID Variants

SUNDAY, July 21, 2024 -- As yet another batch of variants fuel a COVID surge this summer, one expert offers advice on how to navigate the threat. “We've seen a bit of a...

Current Gene Screens Miss Many at High Cancer Risk: Study

THURSDAY, July 19, 2024 -- As good as many genetic tests might be, a deeper look at the DNA of over 44,000 people identified many who carried genes that hike their risks for...

Too Many Breast Cancer Survivors Miss Out on Genetic Screening

FRIDAY, July 19, 2024 -- Many breast cancer patients aren’t getting genetic counseling and testing that could help them get the most effective treatment, a new study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.